JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has scheduled a board meeting on 02/11/2026 to consider and approve the un-audited financial results for the quarter and half year ended 30th September, 2026.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has issued a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has announced the scrutinizer report and voting results of its 22nd Annual General Meeting, which was held on September 26, 2026. The meeting approved the audited standalone financial statements for the financial year ended March 31, 2026, and the audited consolidated financial statements for the same period. The company also appointed Mr. Paramvir Singh as a director, liable to retire by rotation.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd held its 22nd Annual General Meeting (AGM) on September 26, 2026, through video conference. The meeting was attended by 88 members, and the requisite quorum was present. The Chairman, Mr. R. C. Venkateish, addressed the members and delivered his speech, apprising them of the company's performance and future outlook. The meeting transacted business, including the adoption of audited financial statements and the appointment of a new director.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has published a newspaper advertisement regarding the dispatch of its 22nd Annual General Meeting (AGM) notice, scheduled to be held on September 26, 2026, through video conferencing.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has announced the 22nd Annual General Meeting (AGM) to be held on September 26, 2026, through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting will consider and adopt the audited standalone financial statements for the financial year ended March 31, 2026, and the reports of the Board of Directors and Statutory Auditor thereon. The proceedings of the AGM will be deemed to be conducted at the Registered Office of the Company.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has released its Annual Report for FY 2025-26, highlighting continued growth and a strong focus on business fundamentals, operational capabilities, and customer relationships. The company recorded revenue from operations of ₹101.69 Crores during FY 2025-26, reflecting growth and the strength of its manufacturing capabilities and customer relationships.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has informed about the publication of Newspaper Advertisement regarding the details of Annual General Meeting.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has published its unaudited financial results for the quarter ended June 30, 2026, in newspapers and on its website.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has filed a statement of deviation and variation for the quarter ended June 30, 2026, under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, regarding the utilization of funds raised through a preferential issue.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has announced its un-audited financial results for the quarter ended 30th June, 2026, with a revenue from operations of Rs. 3,038.05 lakhs and a net profit of Rs. 334.223 lakhs.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has announced its un-audited financial results for the quarter ended 30th June, 2026. The company's revenue from operations was Rs. 3,038.05 lakhs, with other income of Rs. 9.06 lakhs. The total income was Rs. 3,047.11 lakhs. Expenses included cost of materials consumed of Rs. 187.326 lakhs, employee benefits expense of Rs. 25.744 lakhs, and finance costs of Rs. 28.4 lakhs.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has scheduled a board meeting on 11/08/2026 to consider and approve un-audited financial results for the quarter ended 30 June, 2026.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has announced the voting results and scrutinizer's report of its postal ballot, which concluded on July 29, 2026. The resolution to modify the utilization of funds raised through the preferential issue of equity shares and fully convertible warrants was passed with a 99.9333% majority.

JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd has concluded its postal ballot through remote e-voting on July 29, 2026, to seek approval for the modification in the utilization of funds raised through the preferential issue of equity shares and fully convertible warrants.